Novartis-Bayer tie up could also be set to capture a staggering 9% share of the global pharmaceutical market by 2014, significantly ahead of the 7.5% market share that Pfizer secured last year.

到2014年，诺华-拜耳这种并购组合可能会占据全球药品市场9％的份额，明显领先于辉瑞去年达到的7.5％的市场份额。

youdao

Novartis-Bayer tie up could also be set to capture a staggering 9% share of the global pharmaceutical market by 2014, significantly ahead of the 7.5% market share that Pfizer secured last year.

到2014年，诺华-拜耳这种并购组合可能会占据全球药品市场9％的份额，明显领先于辉瑞去年达到的7.5％的市场份额。

youdao